John Mills
Family Medicine · Richmond, VANPI 1790738425
Payments from drug & device makers
Across 147 payments — averaging $13.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$977
- Irhythm Technologies, Inc.$94
- Esperion Therapeutics, Inc.$75
- Xeris Pharmaceuticals, Inc.$62
- Biohaven Pharmaceutical Holding Company Ltd.$60
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$57
- plus $715 from 25 others
What the payments were for
- Food & beverage$2,041100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 86 | $977 |
| Irhythm Technologies, Inc. | 1 | $94 |
| Esperion Therapeutics, Inc. | 4 | $75 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $57 |
| GSK | 4 | $55 |
| Amgen | 4 | $51 |
| Supernus Pharmaceuticals, Inc. | 3 | $51 |
| Boehringer Ingelheim | 3 | $50 |
| Medtronic | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $44 |
| Almatica Pharma LLC | 2 | $39 |
| Novo Nordisk | 3 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| AstraZeneca | 2 | $31 |
| Biohaven Pharmaceuticals, Inc. | 1 | $31 |
| Dexcom, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 2 | $31 |
| Pfizer | 2 | $26 |
| Genentech USA, Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Edwards Lifesciences | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Novartis | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Therapeuticsmd, Inc. | 1 | $12 |
| Bayer | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$2,041 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 11 | $11,355 |
| EliquisApixaban | 12 | $10,332 |
| Memantine Hcl | 11 | $1,025 |
| Atorvastatin Calcium | 57 | $502 |
| Rosuvastatin Calcium | 33 | $468 |
| Pantoprazole Sodium | 20 | $436 |
| Duloxetine Hcl | 15 | $333 |
| Amlodipine Besylate | 35 | $220 |
| Montelukast Sodium | 14 | $219 |
| Escitalopram Oxalate | 12 | $213 |
| Carvedilol | 13 | $190 |
| Losartan Potassium | 11 | $189 |
| Tamsulosin Hcl | 14 | $162 |
| Allopurinol | 11 | $132 |
| Levothyroxine Sodium | 14 | $129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $26 | $10,33212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Richmond
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Banks TurnerRichmond$74K
- James FosterRichmond$27K
- George MaughanRichmond$21K
- Aaron HartmanMidlothian$17.4M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Stephan JannachDanville$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.